Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine

Immunology Letters

Volumn 118, Issue 1, 2008, Pages 65-71

  Dutta, Noton Kumar ^a   Mazumdar, Kaushiki ^b   Lee, Byoung Hee ^b   Baek, Min Won ^a   Kim, Dong Jae ^a   Na, Yi Rang ^a   Park, Sung Hoon ^a   Lee, Hyun Kyoung ^a   Kariwa, Hiroaki ^c   Mai, Le Quynh ^d   Park, Jae Hak ^a  

^a KRF Zoonotic Disease Priority Research Institute   (South Korea)

^b Seoul National University   (South Korea)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

DNA immunization; Epitope; Nucleocapsid; SARS CoV

Indexed keywords

CONCANAVALIN A; DNA FRAGMENT; DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; NUCLEOCAPSID PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; DNA IMMUNIZATION; DRUG DESIGN; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; ANTIBODIES; CELL LINE; CELL PROLIFERATION; EPITOPES; ESCHERICHIA COLI; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NUCLEOCAPSID; SARS VIRUS; T-LYMPHOCYTES; VACCINES, DNA; VIRAL VACCINES;

EID: 43849107974     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.03.003     Document Type: Article

References (35)

1. Drosten C., Gunther S., Preiser W., Werf S.V.D., Brodt H.R., Becker S., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New Engl J Med 348 (2003) 967-976
2. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., et al. The genome sequence of the SARS-associated coronavirus. Science 300 (2003) 1399-1404
3. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
4. Holmes K.V., and Enjuanes L. The SARS coronavirus: a postgenomic era. Science 300 (2003) 1377-1378
5. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., and Fu J.L. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 11 (2004) 362-371
6. Woo P.C.Y., Lau S.K.P., Wong B.H.L., Tsoi H.W., Fung A.M.Y., Chan K.H.T., et al. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 42 (2004) 2306-2309
7. Shi S.Q., Peng J.P., Li Y.C., Qin C., Liang G.D., Xu L., et al. The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization. Mol Immunol 43 (2006) 1791-1798
8. Enjuanes L., Smerdou C., Castilla J., Anton I.M., Torres J.M., Sola I., et al. Development of protection against coronavirus induced diseases, a review. Adv Exp Med Biol 380 (1995) 197-211
9. Takamura K., Matsumoto Y., and Shimizu Y. Field study of bovine coronavirus vaccine enriched with hemagglutinating antigen for winter dysentery in dairy cows. Can J Vet Res 66 (2002) 278-281
10. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol 32 (2003) 567-582
11. Pratelli A., Tinelli A., Decaro N., Cirone F., Elia G., and Roperto S. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol 26 (2003) 151-155
12. Pratelli A., Tinelli A., Decaro N., Cirone F., Elia G., and Roperto S. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol 119 (2004) 129-140
13. Saif L.J. Animal coronavirus vaccines: lessons for SARS. Dev. Biol. (Basel) 119 (2004) 129-140
14. Chang M.S., Lu Y.T., Ho S.T., Wu C.C., Wei T.Y., Chen C.J., et al. Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem Biophys Res Commun 314 (2004) 931-936
15. Surjit M., Liu B., Kumar P., Chow V.T.K., and Lal S.K. The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. Biochem Biophys Res Commun 317 (2004) 1030-1036
16. Kuo L., and Masters P.S. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol 76 (2002) 4987-4999
17. Parker M.M., and Masters P.S. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three-domain structure for the nucleocapsid protein. Virology 179 (1990) 463-468
18. Huang L.R., Chiu C.M., Yeh S.H., Huang W.H., Hsueh P.R., Yang W.Z., et al. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. J Med Virol 73 (2004) 338-346
19. Narayanan K., Chen C.J., Maeda J., and Makino S. Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol 77 (2003) 2922-2927
20. Leung D.T., Tam F.C., Ma C.H., Chan P.K., Cheung J.L., Niu H., et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 190 (2004) 379-386
21. Liu C., Kokuho T., Kubota T., Watanabe S., Inumaru S., Yokomizo Y., and Onodera T. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res 80 (2001) 75-82
22. Gao W., Tamin A., Soloff A., D'Aiuto L., Nwanegbo E., Robbins P.D., et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362 (2003) 1895-1896
23. Okada M., Takemoto Y., Okuno Y., Hashimoto S., Yoshida S., Fukunaga Y., et al. The development of vaccines against SARS corona virus in mice and SCID426 PBL/hu MICE. Vaccine 23 (2005) 2269-2272
24. Kon O.L., Sivakumar S., Teoh K.L., Lol S.H., and Long Y.C. Naked plasmid-mediated gene transfer to skeletal muscle ameliorates diabetes mellitus. J Gene Med 1 (1999) 186-194
25. CDC NIH. Biosafety in microbiological and biomedical laboratories. 4th ed. (1990), US Government Printing Office, Washington, DC
26. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
27. Froebel K.S., Pakker N.G., Aiuti F., Bofill M., Choremi-Papadopoulou H., Economidou J., et al. Standardization and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. J Immunol Methods 227 (1999) 85-97
28. Tripp R.A., Haynes L.M., Moore D., Anderson B., Tamin A., Harcourt B.H., et al. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods 128 (2005) 21-28
29. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., et al. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 50 (2004) 988-995
30. Shang B., Wang X.Y., Yuan J.W., Vabret A., Wu X.D., Yang R.F., et al. Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. Biochem Biophys Res Commun 336 (2005) 110-117
31. Huang Q., Yu L., Petros A.M., Gunasekera A., Liu Z., Xu N., et al. Structure of the N450 terminal RNA-binding domain of the SARS-CoV nucleocapsid protein. Biochemistry 43 (2004) 6059-6063
32. Noad R., and Roy P. Virus-like particles as immunogens. Trends Microbiol 11 (2003) 438-444
33. Kim T.W., Lee J.H., Hung C.F., Peng S., Roden R., Wang M.C., et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 78 (2004) 4638-4645
34. Zhu M.S., Pan Y., Chen H.Q., Yue S., Chun W.X., Jun S.Y., et al. Induction of SARS458 nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 92 (2004) 237-243
35. Vandana G., Tani M.T., Kai S., Ananth C., Azlinda A., Kun Y., et al. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology 347 (2006) 127-139